Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jan 29;11(1):2660.
doi: 10.1038/s41598-021-82098-3.

A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease

Affiliations
Randomized Controlled Trial

A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease

Shaker El-Sappagh et al. Sci Rep. .

Abstract

Alzheimer's disease (AD) is the most common type of dementia. Its diagnosis and progression detection have been intensively studied. Nevertheless, research studies often have little effect on clinical practice mainly due to the following reasons: (1) Most studies depend mainly on a single modality, especially neuroimaging; (2) diagnosis and progression detection are usually studied separately as two independent problems; and (3) current studies concentrate mainly on optimizing the performance of complex machine learning models, while disregarding their explainability. As a result, physicians struggle to interpret these models, and feel it is hard to trust them. In this paper, we carefully develop an accurate and interpretable AD diagnosis and progression detection model. This model provides physicians with accurate decisions along with a set of explanations for every decision. Specifically, the model integrates 11 modalities of 1048 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) real-world dataset: 294 cognitively normal, 254 stable mild cognitive impairment (MCI), 232 progressive MCI, and 268 AD. It is actually a two-layer model with random forest (RF) as classifier algorithm. In the first layer, the model carries out a multi-class classification for the early diagnosis of AD patients. In the second layer, the model applies binary classification to detect possible MCI-to-AD progression within three years from a baseline diagnosis. The performance of the model is optimized with key markers selected from a large set of biological and clinical measures. Regarding explainability, we provide, for each layer, global and instance-based explanations of the RF classifier by using the SHapley Additive exPlanations (SHAP) feature attribution framework. In addition, we implement 22 explainers based on decision trees and fuzzy rule-based systems to provide complementary justifications for every RF decision in each layer. Furthermore, these explanations are represented in natural language form to help physicians understand the predictions. The designed model achieves a cross-validation accuracy of 93.95% and an F1-score of 93.94% in the first layer, while it achieves a cross-validation accuracy of 87.08% and an F1-Score of 87.09% in the second layer. The resulting system is not only accurate, but also trustworthy, accountable, and medically applicable, thanks to the provided explanations which are broadly consistent with each other and with the AD medical literature. The proposed system can help to enhance the clinical understanding of AD diagnosis and progression processes by providing detailed insights into the effect of different modalities on the disease risk.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Selected features for both layers based on three different techniques of SVM, RF, and GB. The first row is for the first layer, and the second row is for the second layer.
Figure 2
Figure 2
SHAP summary plots for the first layer. The upper left figure represents the CN class, the upper right figure represents the MCI class, and the second row represents the AD class.
Figure 3
Figure 3
SHAP summary plots for the second layer. The left figure shows the pMCI class, and the right figure shows the sMCI class.
Figure 4
Figure 4
First layer example predictions for AD (A), CN (B), and MCI (C) and SHAP supervised clustering in model behavior for all cases in each class. Red indicates attributions that push the score higher, while blue indicates contributions that push the score lower. A few of the noticeable subgroups are annotated with the features that define them.
Figure 5
Figure 5
Development process for the oracle model in each layer.
Figure 6
Figure 6
The proposed XAI framework. A variety of data modalities are used to build the predictive model. In addition, a variety of explanations are built for the entire RF behavior and for each prediction. The FreeSurfer version 6.0 is used (https://surfer.nmr.mgh.harvard.edu/).
Figure 7
Figure 7
Multimodal fusion strategies: (a) late fusion, (b) early fusion.
Figure 8
Figure 8
Roles of explainers to enhance RF interpretability.

Similar articles

Cited by

References

    1. Alberdi A, Aztiria A, Basarab A. On the early diagnosis of Alzheimer’s disease from multimodal signals: a survey. Artif. Intell. Med. 2016;71:1–29. doi: 10.1016/j.artmed.2016.06.003. - DOI - PubMed
    1. Masters CL, Beyreuther K. Alzheimer’s centennial legacy: prospects for rational therapeutic intervention targeting the Aβ amyloid pathway. Brain. 2006;129:2823–2839. doi: 10.1093/brain/awl251. - DOI - PubMed
    1. Zamrini E, De Santi S, Tolar M. Imaging is superior to cognitive testing for early diagnosis of Alzheimer’s disease. Neurobiol. Aging. 2004;25:685–691. doi: 10.1016/j.neurobiolaging.2004.02.009. - DOI - PubMed
    1. Liu, M., Zhang, J., Adeli, E. & Shen, D. Joint classification and regression via deep multi-task multi-channel learning for Alzheimer’s disease diagnosis. IEEE Trans. Biomed. Eng. 1 (2018). - PMC - PubMed
    1. Lee G, et al. Predicting Alzheimer’s disease progression using multi-modal deep learning approach. Sci. Rep. 2019;9:1–12. doi: 10.1038/s41598-018-37186-2. - DOI - PMC - PubMed

Publication types